DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
McInnes IB. Mease PJ. Kirkham B. et al.
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet 2015;
386: 1137-1146
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.